HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Grégoire Vuagniaux Selected Research

alisporivir

10/2016HCV1b genome evolution under selective pressure of the cyclophilin inhibitor alisporivir during the DEB-025-HCV-203 phase II clinical trial.
5/2012The cyclophilin inhibitor alisporivir prevents hepatitis C virus-mediated mitochondrial dysfunction.
11/2010Debio-025 is more effective than prednisone in reducing muscular pathology in mdx mice.
4/2008Genetic and pharmacologic inhibition of mitochondrial-dependent necrosis attenuates muscular dystrophy.
9/2007Inhibition of mitochondrial permeability transition improves functional recovery and reduces mortality following acute myocardial infarction in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Grégoire Vuagniaux Research Topics

Disease

4Neoplasms (Cancer)
01/2019 - 11/2014
3Chronic Hepatitis C
10/2016 - 02/2009
3Infections
12/2014 - 03/2009
2Muscular Dystrophies (Muscular Dystrophy)
11/2010 - 04/2008
2Necrosis
11/2010 - 04/2008
2Cystic Fibrosis (Mucoviscidosis)
10/2010 - 01/2007
2Hepatitis C
06/2010 - 02/2009
1Lung Neoplasms (Lung Cancer)
01/2019
1Ovarian Neoplasms (Ovarian Cancer)
12/2018
1Triple Negative Breast Neoplasms
01/2018
1Psoriasis (Pustulosis Palmaris et Plantaris)
11/2014
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2014
1Liver Diseases (Liver Disease)
05/2012
1Mitochondrial Diseases (Mitochondrial Disease)
05/2012
1Fibrosis (Cirrhosis)
11/2010
1Dehydration (Water Stress)
10/2010
1Lung Diseases (Lung Disease)
10/2010
1Hepatocellular Carcinoma (Hepatoma)
03/2009
1Arthritis (Polyarthritis)
01/2009
1Rheumatoid Arthritis
01/2009
1Clinical Deterioration
01/2009
1Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
04/2008
1Myocardial Infarction
09/2007
1Infarction (Infarctions)
09/2007
1Reperfusion Injury
09/2007
1Ischemia
09/2007
1Autosomal Recessive Deafness
11/2002
1Deafness (Deaf Mutism)
11/2002

Drug/Important Bio-Agent (IBA)

5alisporivirIBA
10/2016 - 09/2007
4Proteins (Proteins, Gene)FDA Link
02/2013 - 09/2007
4Cyclophilins (Cyclophilin)IBA
05/2012 - 04/2008
3CaspasesIBA
01/2019 - 09/2015
3Inhibitor of Apoptosis ProteinsIBA
01/2018 - 01/2014
2Leukocyte Elastase (Neutrophil Elastase)IBA
10/2010 - 01/2007
2Cyclosporine (Ciclosporin)FDA LinkGeneric
06/2010 - 09/2007
2Pharmaceutical PreparationsIBA
03/2009 - 02/2009
2InterferonsIBA
03/2009 - 02/2009
1CytokinesIBA
01/2019
1Interleukin-10 (Interleukin 10)IBA
01/2019
1AntibodiesIBA
01/2019
1Carboplatin (JM8)FDA LinkGeneric
12/2018
1Heat-Shock Proteins (Heat-Shock Protein)IBA
11/2014
1CUDC 305IBA
11/2014
1Viral RNAIBA
02/2013
1Prednisone (Sone)FDA LinkGeneric
11/2010
1SodiumIBA
10/2010
1depelestatIBA
10/2010
1Peptide Hydrolases (Proteases)FDA Link
03/2009
1Antiviral Agents (Antivirals)IBA
02/2009
1Ribavirin (Virazole)FDA LinkGeneric
02/2009
1EnzymesIBA
01/2009
1ImmunosorbentsIBA
01/2009
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2009
1Therapeutic UsesIBA
01/2009
1keyhole-limpet hemocyanin (keyhole limpet hemocyanin)IBA
01/2009
1Neutralizing AntibodiesIBA
01/2009
1CalciumIBA
04/2008
1Peptidyl-Prolyl Isomerase FIBA
04/2008
1triphenyltetrazoliumIBA
09/2007
1Mitochondrial Permeability Transition PoreIBA
09/2007
11- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
09/2007
1Serine Proteases (Serine Protease)IBA
11/2002
1Epithelial Sodium ChannelsIBA
11/2002

Therapy/Procedure

3Therapeutics
12/2014 - 02/2009
1Radiotherapy
01/2019
1Heterologous Transplantation (Xenotransplantation)
11/2014
1Ischemic Postconditioning
09/2007
1Intravenous Injections
09/2007